|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.32 EGP | +2.41% |
|
-0.15% | -9.09% |
GlaxoSmithKline S.A.E reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EGP 370.18 million compared to EGP 140.04 million a year ago. Net income was EGP 869.16 million compared to EGP 2.7 million a year ago.
Basic earnings per share from continuing operations was EGP 0.24 compared to basic loss per share from continuing operations of EGP 0.41 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.09% | 56.35M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
GLAXOSMITHKLINE S.A.E 
